Division of Endocrinology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
Transplantation. 2010 May 15;89(9):1126-33. doi: 10.1097/TP.0b013e3181d54bb9.
BACKGROUND.: Pancreas transplantation (PT) provides the best glycemic control option for diabetes mellitus but is associated with significant morbidities related to infectious disease. METHODS.: We performed a retrospective study of a cohort of consecutive PT recipients in whom PT was performed from 1998 to 2006 (n=216) and followed up them until July 2008. Data regarding infections, rejection, infection chemoprophylaxis, graft failure, absolute lymphocyte counts (ALCs), and mortalities were collected. RESULTS.: Simultaneous pancreas and kidney, pancreas transplantation alone, and pancreas after kidney (PAK) transplantations were performed in 42, 67, and 107 patients, with a mean (standard deviation) age at transplantation of 46.8 (8.03), 40.6 (10.1), and 43.7 (8.19) years. Of the simultaneous pancreas and kidney, pancreas transplantation alone, and PAK transplant recipients, 54.7%, 37.3%, and 58.8% were men. Overall, 63% developed a serious infection during the median follow-up of 6.4 years. Mean (range) number of infectious episodes was 2.3 (1-12), with mostly bacterial infections both within (68%) and after 1 year (78%). Incidence of bacterial and viral infections was greatest in the first 3 months after transplantation. Fungal infections were more constant. Bladder exocrine drainage was associated with higher risk of infection (hazard ratio=2.5, P<0.001). Infection within the first 3 months after transplantation was related to higher mortality after the first 3 months (hazard ratio=3.19). ALC was associated with the risk of first infections (P=0.005) and bacterial infections (P<0.001). CONCLUSIONS.: Incidence of infections after PT was 63% and mostly bacterial. Bladder drainage increases infection risk and low ALC partially predicts episodes. Limitations include retrospective design, unequal composition of PT groups, and lack of data between kidney and PT for PAK.
胰腺移植(PT)为糖尿病患者提供了最佳的血糖控制选择,但与与传染病相关的重大发病率有关。方法:我们对 1998 年至 2006 年期间连续进行胰腺移植的一组患者进行了回顾性研究(n=216),并随访至 2008 年 7 月。收集了感染、排斥、感染化学预防、移植物衰竭、绝对淋巴细胞计数(ALC)和死亡率的数据。结果:42 例患者进行了胰肾联合移植,67 例患者进行了单纯胰腺移植,107 例患者进行了胰腺后肾(PAK)移植,移植时的平均(标准差)年龄分别为 46.8(8.03)、40.6(10.1)和 43.7(8.19)岁。胰肾联合移植、单纯胰腺移植和 PAK 移植患者中,54.7%、37.3%和 58.8%为男性。总的来说,63%的患者在中位 6.4 年的随访期间发生了严重感染。平均(范围)感染发作次数为 2.3(1-12),大多数是细菌感染,无论是在(68%)还是在 1 年后(78%)。细菌和病毒感染的发生率在移植后前 3 个月最高。真菌感染更稳定。膀胱外分泌引流与感染风险增加相关(风险比=2.5,P<0.001)。移植后前 3 个月内发生的感染与移植后前 3 个月后的死亡率升高相关(风险比=3.19)。ALC 与首次感染的风险相关(P=0.005)和细菌感染相关(P<0.001)。结论:PT 后感染的发生率为 63%,主要为细菌感染。膀胱引流增加感染风险,低 ALC 部分预测发作。局限性包括回顾性设计、PT 组构成不均、PAK 中缺乏肾与 PT 之间的数据。